Atopic Dermatitis

Case 3 Continued: How to Have Conversation About Risk of Biologics and Length of Therapy

Joshua Zeichner, MD; Brittany Craiglow, MD; Elizabeth Swanson, MD; Vikash Oza, MD; and Raj Chovatiya, MD, PhD, provide take-home messages for dermatologists treating pediatric patients with atopic dermatitis.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD, MSCI

Case 3 Continued: Impressions

Atopic dermatitis specialists discuss how to have a conversation with parents about risks of biologics and how to answer questions about length of therapy.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD, MSCI

Case 3: 12-Year-Old-Female With Atopic Dermatitis

Expert pediatric dermatologists provide impressions on the case of a 12-year-old girl with atopic dermatitis.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD, MSCI

Shin Guard Dermatitis: What's the Diagnosis?

Joshua Zeichner, MD, reviews the case of a 12-year-old girl with atopic dermatitis.

Nuthan Bhat ;Bernard A. Cohen, MD

September 8th 2022

A new allergen, acetophenone azine with generalized autoeczematization, is the cause of “shin guard dermatitis.”

New Study Finds Skin Immune Biomarker Test Helps Predict Eczema in Babies

Carrie Nagorka, Senior Editor

September 7th 2022

New sticky tape study can help predict onset of pediatric atopic eczema in babies.

Case 2 Continued: Importance of Combination Therapy and Shared Decision Making

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD, MSCI

Case 2 Continued: Barriers to Treatment Adherence

Expert pediatric dermatologists discuss the importance of combination therapy and shared decision-making when treating pediatric patients with atopic dermatitis.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD, MSCI

Case 2 Continued: Impressions and Recommendations

Brittany Craiglow, MD, and Joshua Zeichner, MD, discuss treatment adherence in pediatric patients with atopic dermatitis.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD, MSCI

Case 2 Continued: Addressing Injectable Medications in Children

Vikash Oza, MD, provides clinical insight for Case 2, a 7-year-old female patient with atopic dermatitis.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD, MSCI

Case 2: 7-Year-Old Female With Atopic Dermatitis

Joshua Zeichner, MD; Brittany Craiglow, MD; Elizabeth Swanson, MD; and Vikash Oza, MD, address techniques for injectables when treating pediatric patients with atopic dermatitis.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD, MSCI

Case 1 Continued: Treatments Beyond Topical Agents and the Use of Dupixent

Dr Joshua Zeichner reviews the case of a 7-year-old female patient with atopic dermatitis.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD, MSCI

Case 1 Continued: Clinical Impressions

Joshua Zeichner, MD; Brittany Craiglow, MD; Elizabeth Swanson, MD; Vikash Oza, MD; and Raj Chovatiya, MD, PhD, discuss treatments beyond topical agents and the use of dupilumab in pediatric patients with atopic dermatitis.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD, MSCI

Case 1: 2-Year-Old Male With Atopic Dermatitis

Expert pediatric dermatologists Drs Elizabeth Swanson, Joshua Zeichner, and Raj Chovatiya share impressions from patient case No. 1.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD, MSCI

Arcutis Finalizes Enrollment in Pivotal Phase 3 Trial of Roflumilast Cream for AD

Dr Joshua Zeichner reviews the case of a 2-year-old patient with atopic dermatitis.

Kaitlyn Bader, Associate Editor

August 25th 2022

INTEGUMENT-1 and 2 trial data for atopic dermatitis are expected at the end of 2022.

Gaps in Management of AD SOC Patients

Neal Bhatia, MD;Angela Lamb, MD;Omar Noor, MD, FAAD

August 23rd 2022

Drs Angela Lamb, Omar Noor, and Neal Bhatia share what they consider to be the biggest gaps in care for patients with SOC: patient/provider education, building trust, and appropriate diagnosis of AD.

AD Patient Case: FST III

Neal Bhatia, MD;Angela Lamb, MD;Omar Noor, MD, FAAD

August 23rd 2022

Three dermatologists discuss the case of an 18-year-old patient with AD who is exploring nonsteroidal options to manage his disease.

Clinical Presentations of Pediatric AD and Shin Guard Dermatitis

Kaitlyn Bader, Associate Editor

August 23rd 2022

Peter Lio, MD, clinical professor of dermatology and pediatrics at Northwestern University Feinberg School of Medicine in Chicago, Illinois, discusses how atopic dermatitis presents differently in pediatric patients, and the 2021 allergen of the year, acetophenone azine associated with shin guard dermatitis.

Atopic Dermatitis Remains Controlled Even After Reduction of Dupilumab Dose

Lauren Joszt

August 17th 2022

Patients with persistently controlled atopic dermatitis who had their doses reduced were able to maintain their low disease activity.

The Cutaneous Connection: Pediatric Atopic Dermatitis and Shin Guard Dermatitis

Kaitlyn Bader, Associate Editor

August 16th 2022

In this episode, Peter Lio, MD, and clinical professor of dermatology and pediatrics at Northwestern University Feinberg School of Medicine, discusses how atopic dermatitis presents differently in pediatric patients, and the 2021 allergen of the year, acetophenone azine associated with shin guard dermatitis.

Cost and Access to AD Treatments

Neal Bhatia, MD;Angela Lamb, MD;Omar Noor, MD, FAAD

August 16th 2022

Drs Noor and Bhatia have a conversation about cost and financial assistance from pharmaceutical companies.

AD Patient Case: FST V

Neal Bhatia, MD;Angela Lamb, MD;Omar Noor, MD, FAAD

August 16th 2022

Drs Bhatia and Lamb discuss the case of a 12-year-old child with asthma and how they would manage his disease.

Pharmacological Options for the Treatment of Pediatric Atopic Dermatitis

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD, MSCI

Burden of Atopic Dermatitis in Pediatric Patients

Experts treating pediatric atopic dermatitis discuss the pharmacological options for the treatment of pediatric atopic dermatitis.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD, MSCI

Presentation and Diagnosis of Atopic Dermatitis in Pediatrics

Expert pediatric dermatologists Elizabeth Swanson, MD, and Joshua Zeichner, MD, discuss the burden of pediatric atopic dermatitis.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD, MSCI

Psychological Impact of Atopic Dermatitis in Pediatric Patients

Brittany Craiglow, MD; Raj Chovatiya, MD, PhD; and Joshua Zeichner, MD, discuss the presentation of pediatric patients with atopic dermatitis and how to properly assess and diagnose pediatric patients’ atopic dermatitis.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD, MSCI

Mechanism of Action for Agents Used to Treat Pediatric Atopic Dermatitis

Elizabeth Swanson, MD, and Joshua Zeichner, MD, discuss the psychological factors impacting pediatric patients’ atopic dermatitis.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD, MSCI

Characteristics of Type 2 Inflammation and the Impact of Itch

Joshua Zeichner, MD, and Raj Chovatiya, MD, PhD, dive deep into the pathogenesis of atopic dermatitis and discuss how agents treating atopic dermatitis work.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD, MSCI

When to Progress to Systemic Therapy

Joshua Zeichner, MD, and Vikash Oza, MD, discuss characteristics of type 2 inflammation and the impact of itching on pediatric patients with atopic dermatitis.

Nicholas Brownstone, MD